Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
Vaezi et al., Advances in Respiratory Medicine, doi:10.3390/arm91010004
https://c19early.org/vaezi.html